American Health Packaging recalls Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manu…
- Recall date
- May 9, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1467-2019
- FDA classification
- Class II
- Brand / firm
- American Health Packaging
- Sold / distributed
- Nationwide USA
Why it was recalled
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Get recall alerts
Free email alert whenever American Health Packaging has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: American Health Packaging